Get started
Author

Mohammad M. Alhousani

Observed names: Mohammad Alhousani, Mohammad M Alhousani
Institution: Mayo Clinic
ORCID: 0000-0002-4345-8770
Observed ORCID: 0000-0002-4345-8770
OpenAlex ID: A5030843375
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients
2025 · Ali Alsugair, Estefania Gauto Mariotti, et al. · Blood Cancer Journal · 3
PDF
A national inpatient sample analysis for CAR-T cell therapy administration.
2022 · Veli Bakalov, Amy Tang, et al. · Journal of Clinical Oncology · 2
Low (0.1% to ≤ 1%) or Very Low (0.06% to < 0.1%) JAK2 V617F Allele Burden in Routine Testing: Clinical Correlates and Clonal Trajectory
2025 · Ruah Alyamany, Ahmed Alnughmush, et al. · American Journal of Hematology · 1
PDF
Risk-adjusted comparison of survival in chronic myelomonocytic leukemia with and without allogeneic stem cell transplant: Mayo Clinic experience in 775 consecutive patients
2025 · Ali Alsugair, Saubia Fathima, et al. · American Journal of Hematology
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: Analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients.
2025 · Ali Alsugair, Estefania Gauto Mariotti, et al. · Journal of Clinical Oncology
PDF
Low-Dose Acyclovir Reduces the Reactivation of Herpes Simplex and Varicella Zoster Viruses After Allogeneic Stem Cell Transplantation
2024 · Sorana G Ursu, Mohammad M Alhousani, et al. · Cureus
Inpatient outcomes of blinatumomab use: A national inpatient sample analysis.
2022 · Veli Bakalov, Amy Tang, et al. · Journal of Clinical Oncology
Works count: 7
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type